If you're in Delhi, Agra, Cuttack, Surat, or Kollam, you can now walk into a RedWing dealership and book the new Honda QC3 for a token of Rs 5,000. At Rs 1.35 lakh (ex-showroom New Delhi), it slots directly into the crowded mid-tier electric scooter segment, sitting squarely against the TVS iQube, Bajaj Chetak, and Ather Rizta. For everyone else, the launch is effectively a digital event—Honda has confirmed a phased rollout, meaning availability is currently restricted to those five metropolitan hubs.
The core hardware is practical rather than flashy. Honda has opted for a fixed 3kWh battery pack, a deliberate departure from the swappable architecture seen in some of its other EVs. This setup promises a 145 km IDC range, which is decent for urban commuting but requires planning for longer trips. Charging times are standard for the class: roughly 2 hours and 40 minutes to reach 80% capacity, or about four hours for a full top-up.
Under the seat, you get 32 litres of storage space—enough for a helmet and daily gear, but don't expect to fit a large bag. The cockpit features a 5-inch TFT display with Honda RoadSync connectivity, offering turn-by-turn navigation that keeps the phone in your pocket. Visually, it’s understated, available in four shades including Matt Photon Gray Metallic and Pearl Shallow Blue.
The real question for buyers isn't just the sticker price, but the on-road reality. In a segment where service network density often dictates brand loyalty, Honda’s limited initial city presence is a significant hurdle. While the fixed battery offers reliability, the lack of immediate nationwide availability puts the QC3 at a disadvantage against established players who have wider dealer footprints.
Watch the next six months closely. Honda has promised expansion to more cities, but until that happens, the QC3 remains a niche option for a specific geographic audience. For the rest of India, the TVS iQube and Ather Rizta continue to hold the fort, forcing Honda to prove that its EV strategy can scale beyond the initial trial run.